Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04172584
Other study ID # Emergency contraception.
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 1, 2019
Est. completion date January 1, 2021

Study information

Verified date November 2019
Source Assiut University
Contact Marian Agaiby, doctor
Phone 01200612264
Email agaiby49@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

General objective:

To decrease the percentage of unwanted and/or unplanned pregnancies and their consequences on women's reproductive health.

Specific objectives:

1. To assess awareness of the study participants about emergency contraception.

2. Determine the percentage of ever use among the participants.

3. To identify factors that affect the awareness and use of emergency contraception among the study participants


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 400
Est. completion date January 1, 2021
Est. primary completion date December 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years to 45 Years
Eligibility Inclusion Criteria:

- Married women in reproductive age (15 - 49 years)

Exclusion Criteria:

- Infertile and postmenopausal women.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
correct use of the contraceptions
know the emergency contraception and how to use

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (3)

Association of Women's Health, Obstetric and Neonatal Nurses. Emergency Contraception. J Obstet Gynecol Neonatal Nurs. 2017 Nov - Dec;46(6):886-888. doi: 10.1016/j.jogn.2017.09.004. — View Citation

Mittal S. Emergency contraception: which is the best? Minerva Ginecol. 2016 Dec;68(6):687-99. Epub 2016 Apr 15. Review. — View Citation

Mohammed S, Abdulai AM, Iddrisu OA. Pre-service knowledge, perception, and use of emergency contraception among future healthcare providers in northern Ghana. Contracept Reprod Med. 2019 Jan 24;4:1. doi: 10.1186/s40834-018-0082-9. eCollection 2019. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percent of awareness and use of emergency contraception when to use emergency contraception to prevent the unwanted pregnancy baseline
See also
  Status Clinical Trial Phase
Completed NCT00271583 - Efficacy Trial of CDB 2914 for Emergency Contraception Phase 2/Phase 3
Completed NCT00777556 - Emergency Contraception Actual Use Study Phase 3
Completed NCT00677755 - Medical Abortion for Emergency Contraception Failure N/A
Recruiting NCT06162611 - Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo Phase 4
Completed NCT00411684 - Safety and Efficacy of CDB-2914 for Emergency Contraception Phase 3
Completed NCT01569737 - Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
Completed NCT03208985 - A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions Phase 3
Completed NCT02078414 - Continued Use of Effective Contraception After Use of Emergency Contraception
Completed NCT01569113 - Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo. Phase 4
Completed NCT01963962 - Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception N/A
Recruiting NCT03120728 - Application for the Etonogestrel/Ethinyl Estradiol Ring Phase 4
Active, not recruiting NCT02076217 - Quick Start of Highly Effective Contraception
Completed NCT03395756 - Depot Medroxyprogesterone Acetate as Emergency Contraception Early Phase 1
Completed NCT03614494 - Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception Phase 2/Phase 3